(Q74444155)
Statements
Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results (English)
Bassan R
Chiodini B
Lerede T
Cornelli PE
Cortelazzo S
1 January 1998